Posted in Drug Talk
The Johor Premiere of AstraZeneca M+ Series 2026: Advancing Cardiorenal-Metabolic Care in Johor
Last night, I had the privilege of speaking at The Johor Premiere – AstraZeneca M+ Series 2026, a scientific educational meeting that brought together healthcare professionals from across Johor to discuss the latest advances in cardiovascular, renal, and metabolic medicine. The evening focused on one important goal—delivering better outcomes for patients through earlier intervention, multidisciplinary […]